跳至主要内容
临床试验/NCT03377998
NCT03377998Unknown不适用

Expression of Erythroid Differentiation Regulator 1 (Erdr1) Cytokine in the Vitiliginous Skin Lesions: a Case Control Study

Cairo University0 个研究点目标入组 100 人开始时间: 2018年1月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
100
主要终点
Expression of tissue levels of erythroid differentiation regulator 1 (Erdr1) cytokine in patients of vitiligo

研究概览

简要总结

Expression of Erythroid differentiation regulator 1 (Erdr1) cytokine in vitiligo

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with generalized non-segmental vitiligo.
  • Both sexes.
  • Age >18 years old.
  • New cases or cases not receiving any medication for at least 3 months ago.

排除标准

  • Segmental or Universal vitiligo
  • Autoimmune diseases

研究组 & 干预措施

vitiligo patients

Experimental

lesional skin biopsy to measure ERDR1 level

干预措施: skin biopsy (Other)

controls

Experimental

normal skin biopsy to measure ERDR1 level

干预措施: skin biopsy (Other)

结局指标

主要结局

Expression of tissue levels of erythroid differentiation regulator 1 (Erdr1) cytokine in patients of vitiligo

时间窗: 6 months

Expression of tissue levels of erythroid differentiation regulator 1 (Erdr1) cytokine in patients of vitiligo and comparing its level in normal subjects

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maha Fathy Elmasry

principal investigator

Cairo University

相似试验